PWR Parkinson's Disease-Specific Exercise Protocols 2 — Questions and Answers
Question 1: Which PWR! Move is specifically designed to address the truncal flexion posture commonly seen in Parkinson's disease?
- PWR!Rock
- PWR!Twist (Correct answer)
- PWR!Stand
- PWR!Step
Correct answer: PWR!Twist
PWR!Twist targets trunk rotation and extension, directly counteracting the forward-flexed posture characteristic of Parkinson's disease.
Question 2: In Parkinson's disease exercise programming, what is the primary rationale for incorporating high-amplitude movements?
- To increase heart rate for cardiovascular benefit
- To recalibrate sensorimotor pathways that are impaired by dopamine deficiency (Correct answer)
- To build maximal muscle strength
- To improve peripheral circulation
Correct answer: To recalibrate sensorimotor pathways that are impaired by dopamine deficiency
High-amplitude movements in PWR and LSVT BIG programs recalibrate the sensorimotor system because PD impairs the internal sense of movement size, causing patients to consistently undershoot.
Question 3: A client with Parkinson's disease demonstrates festination during gait. Which exercise strategy is MOST appropriate to address this symptom?
- Increasing treadmill incline
- Using auditory rhythmic cueing with a metronome (Correct answer)
- Performing seated leg press exercises
- Practicing backward walking exclusively
Correct answer: Using auditory rhythmic cueing with a metronome
Auditory rhythmic cueing (metronome or music) provides an external rhythm that helps override the disrupted internal timing mechanisms causing festination in PD.
Question 4: What is the recommended exercise intensity range for aerobic training in individuals with Parkinson's disease to potentially achieve neuroprotective effects?
- 30–40% of heart rate reserve
- 50–60% of heart rate reserve
- 70–80% of heart rate reserve (Correct answer)
- 85–95% of heart rate reserve
Correct answer: 70–80% of heart rate reserve
Research suggests aerobic exercise at 70–80% of heart rate reserve may promote BDNF release and neuroprotective effects in Parkinson's disease.
Question 5: Which dual-task training approach is MOST appropriate for an individual in Hoehn and Yahr Stage 2 Parkinson's disease?
- Avoid all dual-task activities due to fall risk
- Begin with simple cognitive tasks paired with stationary exercises before progressing to walking (Correct answer)
- Immediately pair complex cognitive tasks with balance challenges
- Use dual-task training only in aquatic environments
Correct answer: Begin with simple cognitive tasks paired with stationary exercises before progressing to walking
Dual-task training should be introduced progressively, starting with simple cognitive tasks during stationary exercise before adding the challenge of ambulation.
Question 6: A PWR! Moves therapist is working with a client who has difficulty initiating movement. Which technique is MOST evidence-based for addressing akinesia?
- Passive range of motion exercises
- Attentional strategies with visual or auditory cues (Correct answer)
- Massage and soft tissue mobilization
- Passive stretching of the hip flexors
Correct answer: Attentional strategies with visual or auditory cues
Attentional strategies using external visual or auditory cues help bypass the impaired basal ganglia-thalamo-cortical loop that causes akinesia in PD.
Question 7: When prescribing resistance training for a person with Parkinson's disease, which approach best supports both motor function and neuroplasticity?
- Low load, high repetition training to avoid fatigue
- High load, low repetition training at 70–80% 1RM (Correct answer)
- Isometric-only exercises to reduce fall risk
- Resistance bands used only in the supine position
Correct answer: High load, low repetition training at 70–80% 1RM
High-load resistance training at 70–80% of 1RM has demonstrated superior improvements in strength, motor function, and BDNF-mediated neuroplasticity in PD populations.
Which PWR! Move is specifically designed to address the truncal flexion posture commonly seen in Parkinson's disease?